Danicamtiv
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Danicamtiv, covering 2024-05-23 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy [Phase 2, Phase 3]